Create
Query
event_store.db
—
signals
actions
agent_runs
approvals
artifacts
attention_candidates
commitments
constraints
conversation_compaction
conversation_state
conversation_turns
dead_letters
decisions
deliveries
effects
email_messages
email_reply_drafts
email_threads
entities
entity_aliases
entity_tags
episode_context_index
episodes
event_subjects
events
events_archive
fact_sources
facts
inbox_items
inbox_links
intel_narrative_members
intel_narratives
jobs
leader_leases
links
memory_candidates
memory_embeddings
memory_items
memory_items_fts
(v)
memory_items_fts_config
memory_items_fts_data
memory_items_fts_idx
opportunity_memory
pending_interactions
proposal_sources
proposals
reminders
schedules
schema_migrations
signal_candidates
signal_fps
signals
sms_conversations
sms_messages
sms_reply_drafts
source_cursors
sources
sqlite_sequence
sqlite_stat1
stream_cursors
threads
watchers
Toggle helper tables
memory_items_fts_content
memory_items_fts_docsize
memory_items_fts_segdir
memory_items_fts_segments
memory_items_fts_stat
Structure
Content
Query
Insert
Drop
Import
Export
Update row sig_129e5a38753d in signals
id
sig_129e5a38753d
Primary key.
TEXT
event_id
478482
TEXT NOT NULL
watcher_id
NULL
TEXT
signal_type
discovery_sec_filing_delta
TEXT NOT NULL
value
{"aggregator_url":"https://www.sec.gov/Archives/edgar/data/1581280/0001214659-26-004893.txt","as_of":"2026-04-22T03:03:32.063787+00:00","canonical_url":"https://www.sec.gov/Archives/edgar/data/1581280/0001214659-26-004893.txt","company":"Twist Bioscience Corp","enrichment":{"aggregator_url":"https://www.sec.gov/Archives/edgar/data/1581280/0001214659-26-004893.txt","article_chars":1631,"article_truncated":false,"blocked_reason":null,"candidate_id":"sc_4d6027d91fff00ff","canonical_host":"sec.gov","canonical_is_aggregator":false,"canonical_url":"https://www.sec.gov/Archives/edgar/data/1581280/0001214659-26-004893.txt","content_type":"text/plain","enriched_at":"2026-04-22T03:17:06.032224+00:00","extraction_method":"trafilatura","fetched_description":"","fetched_title":"","final_url":"https://www.sec.gov/Archives/edgar/data/1581280/0001214659-26-004893.txt","html_truncated":false,"paywall_likely":false,"publisher_domain":"sec.gov","publisher_resolution":"canonical_url","requested_url":"https://www.sec.gov/Archives/edgar/data/1581280/0001214659-26-004893.txt","source_event_id":"evt_aebdbfa8a03d","source_quality":"medium","status_code":200,"version":"signal_enrichment_v2"},"form_type":"4","fp":"93922d193462e56c","kind":"sec_filing","published_at":"20260421","publisher_domain":"sec.gov","signal_understanding":{"analysis_basis":"article","claim_confidence":0.72,"dates_mentioned":["2026-04-17","2026-04-21","2025-05-08"],"entities":[{"asset_class":"equity","name":"Twist Bioscience Corp","relevance":"high","symbol":"TWST","type":"issuer"},{"asset_class":"equity","name":"Adam Laponis","relevance":"high","symbol":"","type":"reporting_person"},{"asset_class":"equity","name":"Kendra Fox","relevance":"low","symbol":"","type":"attorney_in_fact"}],"event_type":"listing","information_gaps":["The cleaned text does not include the specific transaction details (e.g., number of shares, price, whether it was a buy/sell, and any remaining holdings).","The signal headline says \u201cTWST filed 4,\u201d but the exact change vs prior known state is not provided in the supplied text (no prior filing comparison data included).","No explicit description of the transaction type (purchase/sale) is present in the provided excerpt beyond the Rule 10b5-1 statement."],"key_facts":["SEC filing is Form 4 (SEC Act: 1934 Act; SEC file number 001-38720).","Issuer: Twist Bioscience Corp (TWST).","Reporting person: Adam Laponis, identified as Chief Financial Officer.","Conformed period of report: 20260417.","Filed as of date: 20260421.","The transaction is stated to be effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person on May 8, 2025.","The filing includes a signature: /s/ Kendra Fox, as Attorney-in-Fact for Adam Laponis, dated 2026-04-21."],"numeric_claims":[{"label":"Rule 10b5-1 plan adoption date","value":"2025-05-08"},{"label":"Conformed period of report","value":"2026-04-17"},{"label":"Filed as of date","value":"2026-04-21"}],"primary_claim":"The Form 4 filed on 2026-04-21 reports a common stock transaction by Adam Laponis, effected under a Rule 10b5-1 trading plan adopted May 8, 2025.","relevance_score":0.55,"sentiment":"neutral","source_quality":"medium","summary":"Twist Bioscience Corp (TWST) filed a Form 4 on 2026-04-21 reporting a transaction by Adam Laponis (CFO) for common stock, dated for the reporting period 2026-04-17. The filing states the trade was executed under a Rule 10b5-1 trading plan adopted on May 8, 2025.","topics":["SEC Form 4","insider trading","Rule 10b5-1 trading plan","common stock transaction","Twist Bioscience Corp"]},"source":"sec_edgar","source_domain":"sec.gov","summary":"Form 4 \u00b7 Twist Bioscience Corp \u00b7 Filed 20260421","ticker":"TWST","tickers":["TWST"],"title":"TWST filed 4","url":"https://www.sec.gov/Archives/edgar/data/1581280/0001214659-26-004893.txt"}
TEXT NOT NULL
threshold
NULL
TEXT
direction
NULL
TEXT
severity
NULL
TEXT
window
NULL
TEXT
source
discovery_sec_filings
TEXT NOT NULL
reason_trace
{"_evidence_event_ids":["evt_aebdbfa8a03d"]}
TEXT
dedupe_key
signal_enriched:discovery_sec_filing_delta:b265cecd2799503e
TEXT NOT NULL
throttle_s
INTEGER (default 0
created_at
2026-04-22T03:03:32.063787+00:00
TEXT NOT NULL (default strftime('%Y-%m-%dT%H:%M:%fZ','now')
Update
Cancel